NovartisCH0012005267NOVNNOVN
![Novartis logo](https://static.getquin.com/logos/CH0012005267.png)
Financials
Market Cap
$237.40B5Y beta
0.92EPS (TTM)
$7.408Free Float
1.87BP/E ratio (TTM)
14.63Revenue (TTM)
$47.97BEBITDA (TTM)
$21.93BFree Cashflow (TTM)
$5.15BPricing
Analyst Ratings
The price target is $112.38 and the stock is covered by 26 analysts.
Buy
12
Hold
12
Sell
2
Information
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.